Antimicrobial resistance in Libya: 1970-2011

Libyan Journal of Medicine

Volumn 8, Issue 1, 2013, Pages

  Ghenghesh, Khalifa Sifaw ^a   Rahouma, Amal ^a   Tawil, Khaled ^a   Zorgani, Abdulaziz ^a   Franka, Ezzedin ^a  

^a UNIVERSITY OF TRIPOLI   (Libyan Arab Jamahiriya)

Author keywords

Antibiotic resistance; Enteric bacteria; Libya; Methicillin resistant Staphylococcus aureus; Multidrug resistant tuberculosis

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BETA LACTAM ANTIBIOTIC; CEFALEXIN; CEFALORIDINE; CEFOTAXIME; CEFTAZIDIME; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; ETHAMBUTOL; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; ISONIAZID; KANAMYCIN; METICILLIN; NALIDIXIC ACID; NORFLOXACIN; OXACILLIN; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TETRACYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ACUTE GASTROENTERITIS; ANTIBIOTIC RESISTANCE; ARTICLE; DISEASE SURVEILLANCE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; GEOGRAPHIC DISTRIBUTION; HAEMOPHILUS INFECTION; HEALTH CARE PERSONNEL; HUMAN; KLEBSIELLA PNEUMONIAE; LIBYAN ARAB JAMAHIRIYA; LUNG TUBERCULOSIS; MEDICAL EDUCATION; MENINGOCOCCOSIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANT TUBERCULOSIS; NONHUMAN; PHARMACIST; PREVALENCE; RESPIRATORY TRACT INFECTION; SALMONELLA; SALMONELLOSIS; SHIGELLA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIA; URINARY TRACT INFECTION; VANCOMYCIN RESISTANT STAPHYLOCOCCUS AUREUS; ENTEROBACTERIACEAE INFECTION; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTION; MULTIDRUG-RESISTANT TUBERCULOSIS; PHYSIOLOGY; REVIEW; SHIGELLOSIS; STAPHYLOCOCCUS INFECTION;

ANTIBIOTIC RESISTANCE; ENTERIC BACTERIA; LIBYA; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG-RESISTANT TUBERCULOSIS;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; DYSENTERY, BACILLARY; ENTEROBACTERIACEAE INFECTIONS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LIBYA; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PREVALENCE; SALMONELLA; SALMONELLA INFECTIONS; SHIGELLA; STAPHYLOCOCCAL INFECTIONS; TUBERCULOSIS, MULTIDRUG-RESISTANT; VANCOMYCIN RESISTANCE;

MLCS; MLOWN;

EID: 84875686209     PISSN: 19932820     EISSN: 18196357     Source Type: Journal    
DOI: 10.3402/ljm.v8i0.20567     Document Type: Article

References (58)

1. Scicluna EA, Borga MA, Gürb D, Rasslan O, Taher I, Redjeb SB, et al. Self-medication with antibiotics in the ambulatory care setting within the Euro-Mediterranean region; results from the ARMed project. J Infect Public Health. 2009; 2: 189-97.
2. el Nageh MM. Salmonella isolations from human faeces in Tripoli, Libya. Trans R Soc Trop Med Hyg. 1988; 82: 324-6.
3. El-Ghodban A, Ghenghesh KS, Marialigeti K, Abeid S. Serotypes, virulence factors, antibiotic sensitivity, betalactamase activity and plasmid analysis of Salmonella from children with diarrhea in Tripoli (Libya). Acta Microbiol Immunol Hung. 2002; 49: 433-44.
4. Salih BA, Kashbur I, Mismari A, Al-Jehani S. Salmonellosis: a common cause of diarrhea among children in Benghazi. Jamahiriya's Second Conference on Medical Sciences, Benghazi, Libya, 8-11 May 1994.
5. Ghenghesh KS, Ali MB, Abuhelfaia A, Dufani MA. High rates of resistance to antibiotics by salmonellae from diarrheic children in Zliten-Libya. 4th European Congress of Chemotherapy and Infection, Paris, France, 4-7 May 2002.
6. Rahouma A, Klena JD, Krema Z, Abobker AA, Treesh K, Franka E, et al. Enteric pathogens associated with childhood diarrhea in Tripoli-Libya. Am J Trop Med Hyg. 2011; 84: 886-91.
7. Sood SC, Bilaziz M, Basbas N. Salmonella enteritis in children in Libya: role of antibiotic therapy. Ann Trop Paediatr. 1986; 6: 93-4.
8. Ghenghesh KS, Bara F, Bukris B, Abeid SS. Shigella-associated diarrhoea in children in Tripoli-Libya. Saudi Med J. 1997; 18: 557-9.
9. Ali M, Ghenghesh KS, Aissa RB, Abuhelfaia A, Dufani MA. Etiology of childhood diarrhea in Zliten-Libya. Saudi Med J. 2005; 26: 1759-65.
10. Mølbak K, Gerner-Smidt P, Wegener HC. Increasing quinolone resistance in Salmonella enterica serotype enteritidis. Emerg Infect Dis. 2002; 8: 514-5.
11. Karaoui RM, Hanna A. An epidemiological study of urinary tract infections in Benghazi, Libya. J Hyg Epidemiol Microbiol Immunol. 1981; 25: 277-85.
12. Gupta K. Emerging antibiotic resistance in urinary tract pathogens. Infect Dis Clin North Am. 2003; 17: 243-59.
13. Altomi AS, Abeid SS, Tloba SE, Rhouma AA, Daw MA, Ghenghesh KS. Urinary tract infections in Tripoli and drug sensitivity of the causative agents. The First Conference on Postgraduate Studies in Medical Sciences, Benghazi, Libya, 31 March-2 April 1997.
14. Ghenghesh KS, Altomi AS, Gashout S, Abouhagar B. High antimicrobial-resistance rates of Escherichia coli from urine specimens in Tripoli-Libya. Garyounis Med J. 2003; 20: 89-93.
15. Tobgi RS, Taher IAA, Ali MB. Antibiotic susceptibility of uropathogens in Benghazi, Libya. Jamahiriya Med J. 2001; 1: 46-9.
16. Bagar SR, Hussein AA, Elahwel AM, Alani SMH. Antibiotic resistance pattern of urinary tract isolates. Jamahiriya Med J. 2007; 7: 116-21.
17. Ghenghesh KS, Elkateb E, Berbash N, Nada RA, Ahmed SF, Rahouma A, et al. Uropathogens from diabetic patients in Libya: virulence factors and phylogenetic groups of isolated Escherichia coli. J Med Microbiol. 2009; 58: 1006-14.
18. Buzayan MM, Tobgi RS, Taher I. Detection of extended spectrum ß-lactamases among urinary Escherichia coli and Klebsiella pneumoniae from two centres. Jamahiriya Med J. 2010; 10: 10-6.
19. Nataro JP, Kaper JB. Diarrheagenic Escherichia coli. Clin Microbiol Rev. 1998; 11: 142-201.
20. Abosak NY, El-Bosifi KM, Hermas RA, Abeid SS, Ghenghesh KS. Antibiotic susceptibility of Escherichia coli isolated from Libyan children with diarrhea. Jamahiriya's Second Conference on Medical Sciences, Benghazi, Libya, 8-11 May 1994.
21. Ali MM. Molecular characterization of virulence factors of Escherichia coli isolated from Egypt and Libya. PhD Thesis, Faculty of Science, Cairo University, Cairo, Egypt, 2011.
22. Ghenghesh KS, Altomi AS, Said MTA. Antibiotic susceptibility of enterobacteria isolated from different sources. Jamahiriya's Second Conference on Medical Sciences, Benghazi, Libya, 8-11 May 1994.
23. Gibreel T, Ghenghesh KS. Extended spectrum beta-lactamases (ESBLs) in Tripoli-Libya (poster presentation). 7th European Congress on Chemotherapy and Infection, Florence, Italy, 19-22 October 2005.
24. Zorgani A, Franka RA, Zaidi MM, Alshweref UM, Elgmati M. Trends in nosocomial bloodstream infections in a burn intensive care unit: an eight-year survey. Ann Burns Fire Disasters. 2010; 23: 88-94.
25. Humphreys H. Staphylococcus. In: Greenwood D, Slack R, Peutherer J, editors. Medical Microbiology. 16th ed. New York: Churchill Livingstone; 2003. p. 168-73.
26. Panlilio AL, Culver DH, Gaynes RP, Banerjee S, Henderson TS, Tolson JS, et al. Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991. Infect Control Hosp Epidemiol. 1992; 13: 582-6.
27. Goda FFM. Antibiotic sensitivity of Staphylococcus aureus isolated from mastitis in cows at Benghazi localities. Bull Animal Health Product Africa. 1976; 24: 47-52.
28. Bauer AW, Kirby WMM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1996; 45: 493-6.
29. Hurlimann-dalel RI, Ryffel C, Kayser FH, Berger-Bachi B. Survey of the methicillin resistance-associated genes meca, mecrl-meci, and fema-femb in clinical isolates of methicillinresistant Staphylococcus aureus. Antimicrob Agents Chemother. 1992; 36: 2617-21.
30. Buzaid N, Elzouki A-N, Taher I, Ghenghesh KS. Methicillinresistant Staphylococcus aureus (MRSA) in a tertiary surgical and trauma hospital in Benghazi, Libya. J Infect Developing Countries. 2011; 5: 723-6.
31. Zorgani A, Shawerf O, Tawil K, El-Turki E, Ghenghesh KS. Inducible clindamycin resistance among staphylococci isolated from burn patients. Libyan J Med. 2009; 4: 149-52.
32. El-Ghodban A, Ghenghesh KS, Márialigeti K, Esahli H, Tawil A. PCR detection of toxic shock syndrome toxin of Staphylococcus aureus from Tripoli, Libya. J Med Microbiol. 2006; 55: 179-82.
33. Ghenghesh KS, Saed NM, El-Ghodban A, Rahouma A, Abeid S. Dirty money: toxigenic and methicillin-resistant Staphylococcus aureus (MRSA) from used bank notes. Jamahiriya Med J. 2001; 1: 54-6.
34. Ellabib MS, Ordonez A, Ramali A, Walli A, Benayad T, Shebrlo H. Changing pattern of neonatal bacteremia. Microbiology and antibiotic resistance. Saudi Med J. 2004; 25: 1951-6.
35. El-Sharef N, Ghenghesh KS, Abognah YS, Gnan SO, Rahouma A. Bacteriological quality of ice cream in Tripoli-Libya. Food Control. 2006; 17: 637-41.
36. Ghenghesh KS, Nashnoush H, Shaker A, Enaami H, Zorgani A. Isolation of methicillin-resistant Staphylococcus aureus (MRSA) from rented DVDs. Am J Infect Control. 2009; 37: 612.
37. Zorgani A, Elahmer O, Franka E, Grera A, Abudher A, Ghenghesh KS. Detection of methicillin-resistant Staphylococcus aureus among healthcare workers in Libyan hospitals. J Hosp Infect. 2009; 73: 91-2.
38. Belgasim Z, Saadaoui A, Zorgani A. Screening for methicillinresistant Staphylococcus aureus among health care workers in the African Oncology Institute, Sabrata-Libya. Am J Infect Control. 2010; 38: 498-9.
39. Borg MA, Scicluna E, Kraker M, Bruinsma N. Antibiotic resistance in the southeastern Mediterranean-preliminary results from the ARMed project. Euro Surveill. 2006; 11: 164-7.
40. Hiramatsu K, Aritaka N, Hanaki H, Kawasaki S, Hosoda Y, Hori S, et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet. 1997; 350: 1670-3.
41. Clinical Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing, 18th Informational Supplement (M100-S18). Wayne, PA: CLSI; 2008.
42. Ahmed MO, Abuzweda A, Alghazali MH, Elramalli AK, Amri SG, Aghila ESH, et al. Misidentification of methicillinresistant Staphylococcus aureus (MRSA) in hospitals in Tripoli, Libya. Libyan J Med. 2010; 5: 5230. doi:10.3402/ljm.v5i0.5230.
43. Howden BP, Davies JK, Johnson PD, Stinear TP, Grayson ML. Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications. Clin Microbiol Rev. 2010; 23: 99-139.
44. Dhand A, Sakoulas G. Reduced vancomycin susceptibility among clinical Staphylococcus aureus isolates ('the MIC Creep'): implications for therapy. F1000 Med Reports. 2012; 4: 4. doi:10.3410/M4-4.
45. WHO (2011). Global tuberculosis control. WHO/HTM/TB/ 2011.16. Geneva: World Health Organization.
46. Health Protection Agency (HPA). World Health Organization (WHO) estimates of tuberculosis incidence by country. 2010 (sorted by rate). Available from: http://www.hpa.org.uk/web/ HPAweb&HPAwebStandard/HPAweb_C/1195733837507 [cited 5 April 2012].
47. Centers for Disease Control and Prevention (CDC). Treatment of tuberculosis. MMWR. 2003; 53: 2.
48. Sharma SK, Mohan A. Multidrug-resistant tuberculosis: a menace that threatens to destabilize tuberculosis control. Chest. 2006; 130: 261-72.
49. WHO (2010). Multidrug and extensively drug-resistant TB (M/ XDR-TB): 2010 global report on surveillance and response. WHO/HTM/TB/2010.3. Geneva: World Health Organization.
50. WHO (2009). Guidelines for surveillance of drug resistance in tuberculosis. 4th ed. WHO/HTM/TB/2009.422. Geneva: World Health Organization.
51. WHO (2008). Anti-tuberculosis drug resistance in the world: fourth global report. WHO/HTM/TB/2008.394. Geneva: World Health Organization.
52. WHO (2013). Tuberculosis profile: Libyan Arab Jamahiriya. Available from: www.who.int/tb/data [cited 15 January 2013].
53. Khalil A, Sathianathan S. Impact of anti-tuberculosis legislation in Libya on the prevalence of primary and acquired resistance to the three main drugs at a major tuberculosis centre. Tubercle. 1978; 59: 1-12.
54. Elghoul MT, Joshi RM, Rizghalla T. Primary and acquired drug resistance in Mycobacterium tuberculosis in western region of Libyan Arab Jamahiriya. Trop Geogr Med. 1989; 41: 304-8.
55. Rao BN, Kashbur IM, Shembesh NM, el Bargathy SM. In vitro antibiotic sensitivity pattern of common bacterial isolates from cases of acute bacterial meningitis with special reference to ceftriaxone. Indian J Pediatr. 1997; 64: 849-54.
56. WHO (2012). The evolving threat of antimicrobial resistance: options for action. Available from: http://whqlibdoc.who.int/ publications/2012/9789241503181 [cited 12 November 2012].
57. Lawson MA. The antibiotic resistance problem revisited. Am Biol Teacher. 2008; 70: 405-10.
58. Wassmer GT, Kipe-Nolt JA, Chayko CA. Why finish your antibiotics? A novel, hands-on, classroom approach for teaching the dynamics of antibiotic resistance. Am Biol Teach. 2006; 68: 476, 478-80.